Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-45,477
Closed -$4.52M 26
2019
Q3
$4.52M Hold
45,477
3.2% 12
2019
Q2
$4.2M Hold
45,477
3.22% 12
2019
Q1
$4.29M Hold
45,477
3.18% 12
2018
Q4
$2.92M Hold
45,477
2.46% 13
2018
Q3
$4.07M Hold
45,477
2.68% 13
2018
Q2
$3.61M Hold
45,477
2.53% 12
2018
Q1
$4.06M Hold
45,477
2.92% 12
2017
Q4
$4.75M Hold
45,477
3.41% 11
2017
Q3
$6.63M Hold
45,477
4.75% 8
2017
Q2
$5.91M Hold
45,477
4.57% 8
2017
Q1
$5.66M Hold
45,477
4.67% 8
2016
Q4
$5.26M Hold
45,477
4.25% 9
2016
Q3
$4.75M Hold
45,477
3.84% 12
2016
Q2
$4.49M Hold
45,477
3.83% 10
2016
Q1
$4.55M Hold
45,477
3.8% 12
2015
Q4
$5.45M Hold
45,477
4.98% 10
2015
Q3
$4.92M Sell
45,477
-1,903
-4% -$236K 4.01% 11
2015
Q2
$5.48M Hold
47,380
3.97% 11
2015
Q1
$5.46M Hold
47,380
3.72% 12
2014
Q4
$5.3M Sell
47,380
-2,820
-6% -$297K 3.72% 12
2014
Q3
$4.76M Hold
50,200
3.34% 12
2014
Q2
$4.31M Hold
50,200
3.12% 13
2014
Q1
$3.5M Buy
50,200
+1,200
+2% +$95K 2.47% 18
2013
Q4
$4.14M Hold
49,000
2.97% 15
2013
Q3
$3.78M Buy
+49,000
New +$3.43M 2.76% 16

Other funds holding CELG

SIB LLC's CELG Position: Q4 2019 in Review

SIB LLC sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 45,477 shares — an estimated $4.52M sold.

SIB LLC first reported a position in CELG in Q3 2013 and held it in 25 quarters. The position peaked at $6.63M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • SIB LLC reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • SIB LLC sold 45,477 Celgene Corp shares in Q4 2019, an estimated $4.52M.
  • SIB LLC first reported a position in Celgene Corp in Q3 2013 and held it in 25 quarters.
  • SIB LLC's Celgene Corp position peaked at $6.63M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on SIB LLC's 13F filing for Q4 2019, filed 21 Jan 2020.